{"id":1167,"date":"2023-03-03T17:10:40","date_gmt":"2023-03-03T16:10:40","guid":{"rendered":"https:\/\/niho.sk\/?post_type=projekty&p=1167"},"modified":"2025-02-07T14:38:13","modified_gmt":"2025-02-07T13:38:13","slug":"tixagevimab-a-cilgavimab-evusheld-%e2%88%92-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022","status":"publish","type":"projekty","link":"https:\/\/www.niho.sk\/en\/projekty\/tixagevimab-a-cilgavimab-evusheld-%e2%88%92-hodnotenie-podla-zakona-c-358-2021-z-z-platneho-od-1-8-2022\/","title":{"rendered":"Tixagevimab a cilgavimab (Evusheld) \u2212 hodnotenie pod\u013ea z\u00e1kona \u010d. 358\/2021 Z.z. \u00fa\u010dinn\u00e9ho od 1.8.2022"},"template":"","stav-projektu":[3],"class_list":["post-1167","projekty","type-projekty","status-publish","hentry","stav-projektu-publikovane-projekty"],"_links":{"self":[{"href":"https:\/\/www.niho.sk\/en\/wp-json\/wp\/v2\/projekty\/1167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.niho.sk\/en\/wp-json\/wp\/v2\/projekty"}],"about":[{"href":"https:\/\/www.niho.sk\/en\/wp-json\/wp\/v2\/types\/projekty"}],"wp:attachment":[{"href":"https:\/\/www.niho.sk\/en\/wp-json\/wp\/v2\/media?parent=1167"}],"wp:term":[{"taxonomy":"stav-projektu","embeddable":true,"href":"https:\/\/www.niho.sk\/en\/wp-json\/wp\/v2\/stav-projektu?post=1167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}